| Stage | VRSN | % of rev | DOCS | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $443M | 100.00% | $157M | 100.00% | VRSN ×2.83 |
| Gross profit | $393M | 88.76% | $133M | 84.87% | VRSN +3.9pp |
| Operating income | $297M | 66.93% | $34M | 21.48% | VRSN +45.4pp |
| Pre-tax income | $280M | 63.12% | $40M | 25.77% | VRSN +37.3pp |
| Net income | $213M | 47.99% | $24M | 15.53% | VRSN +32.5pp |
| Stage | VRSN | DOCS | Gap · A − B |
|---|---|---|---|
| Revenue | $443M100.00% | $157M100.00% | VRSN ×2.83 |
| Gross profit | 88.76%$393M | 84.87%$133M | VRSN +3.9pp |
| Operating income | 66.93%$297M | 21.48%$34M | VRSN +45.4pp |
| Pre-tax income | 63.12%$280M | 25.77%$40M | VRSN +37.3pp |
| Net income |
| 47.99%$213M |
| 15.53%$24M |
| VRSN +32.5pp |